Feed CMRA
CM

Comera Life Sciences Holdings, Inc.

CMRA · OTC

$0.00 +0.00% (+$0.00)
Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Weak
2/9
Valuation
-
N/A
P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A
EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A
Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A
ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A
Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
74 /100
Stable
Beta 1.11x
Rev. volatility N/A
EPS volatility N/A

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about CMRA
Online

About the company

Comera Life Sciences Holdings, Inc. (CLSH) is a biotechnology company specializing in the research and development of therapeutic products aimed at improving human health. With a passion for innovation and scientific advancement, CLSH strives to find new ways of treating and preventing various diseases. Their expert team works on discovering biomarkers and therapeutic targets that can provide new perspectives in medicine. The company is known for its commitment to scientific excellence and ethical standards in research. Comera Life Sciences Holdings, Inc. (CLSH) shares could be suitable for investors interested in the biotechnology sector and supporting innovations aimed at enhancing human health.

Sector

Healthcare

Industry

Biotechnology

CEO

Michael G. Campbell

Employees

12

Headquarters

Woburn

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.